- Home
- DXR vs ENZ Comparison
DXR vs ENZ Comparison
Compare DXR & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- ENZ
- Stock Information
- Founded
- DXR 1970
- ENZ 1976
- Country
- DXR United States
- ENZ United States
- Employees
- DXR N/A
- ENZ N/A
- Industry
- DXR Medical/Dental Instruments
- ENZ Medical Specialities
- Sector
- DXR Health Care
- ENZ Health Care
- Exchange
- DXR Nasdaq
- ENZ Nasdaq
- Market Cap
- DXR 37.6M
- ENZ 34.2M
- IPO Year
- DXR N/A
- ENZ N/A
- Fundamental
- Price
- DXR $8.22
- ENZ $0.66
- Analyst Decision
- DXR Strong Buy
- ENZ
- Analyst Count
- DXR 1
- ENZ 0
- Target Price
- DXR $24.75
- ENZ N/A
- AVG Volume (30 Days)
- DXR 6.8K
- ENZ 139.1K
- Earning Date
- DXR 01-01-0001
- ENZ 03-12-2025
- Dividend Yield
- DXR N/A
- ENZ 59.97%
- EPS Growth
- DXR N/A
- ENZ N/A
- EPS
- DXR 0.35
- ENZ N/A
- Revenue
- DXR $154,205.00
- ENZ $30,314,000.00
- Revenue This Year
- DXR N/A
- ENZ N/A
- Revenue Next Year
- DXR N/A
- ENZ N/A
- P/E Ratio
- DXR $24.39
- ENZ N/A
- Revenue Growth
- DXR N/A
- ENZ N/A
- 52 Week Low
- DXR $7.19
- ENZ $0.63
- 52 Week High
- DXR $10.00
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- DXR 49.04
- ENZ 37.20
- Support Level
- DXR $8.01
- ENZ $0.63
- Resistance Level
- DXR $8.50
- ENZ $0.72
- Average True Range (ATR)
- DXR 0.28
- ENZ 0.04
- MACD
- DXR 0.09
- ENZ 0.01
- Stochastic Oscillator
- DXR 72.98
- ENZ 43.69
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.